All Market Intel

The White House to Drop another Price-Related Executive Order?
Healthcare In Transition | Jul. 17, 2019 | Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Payment reform, Prescription Drug Pricing, Pricing transparency

July 18, 2019 President Trump announced the administration’s intention to release an executive order based on a “favored nations” clause. This approach suggests the U.S. would pay for pharmaceuticals at

Executive Order on Healthcare Pricing Transparency
Healthcare In Transition | Jul. 17, 2019 | Association health plans, Government Affairs, Healthcare, Healthcare reform, Pricing transparency, Short term health plan

June 18, 2019 The White House recently released an executive order aimed at requiring insurers, physicians and hospitals to provide patients with more digestible information about the cost of their

Senate HELP Committee Updates Bill Text on Lower Health Care Costs Act
Healthcare In Transition | Jul. 17, 2019 | Access to Care, Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Payment reform, PBM, Prescription Drug Pricing, Surprise Medical Billing

July 18, 2019 The Council recently expressed strong support for the Lower Health Care Costs Act, which confronts some of the biggest obstacles to bringing costs down in the healthcare

Surprise Billing and Industry Transparency
Healthcare In Transition | Jul. 17, 2019 | Access to Care, Government Affairs, Healthcare, Healthcare costs, Healthcare reform, Payment reform, PBM, Prescription Drug Pricing, Surprise Medical Billing

July 18, 2019 The House Energy and Commerce Committee’s Subcommittee on Health recently marked up and voted in favor of drug transparency and surprise billing legislation. No Surprises Act (H.R.

The Administration Tosses Drug Rebating Rule
Healthcare In Transition | Jul. 17, 2019 | Government Affairs, Healthcare costs, Payment reform, PBM, Prescription Drug Pricing

July 18, 2019 The Trump administration announced it will not pursue its proposal to eliminate prescription drug rebates from government-facilitated health plans. While once touted as a critical step in

The End of the Cadillac Tax?
Healthcare In Transition | Jul. 17, 2019 | Cadillac Tax, Employer Sponsored Insurance, Government Affairs, Healthcare, Healthcare costs, Payment reform

July 18, 2019 The Council has long supported efforts to repeal the Cadillac Tax, and now lawmakers are primed to do just that. The House passed a bill to repeal